4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-036812
Chief Commercial Officer sold 1,551 shares at an average $5.21 ($8,075)
From the SEC's structured data for this filing
Trades in this filing
Cheng Sohanya Roshan · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-13 | Sale : show line 1 in the form | −66 | $5.35 | $353 | 91,434 | D |
| 2022-06-13 | Sale : show line 2 in the form | −1,485 | $5.20 | $7,722 | 89,949 | D |
| Open-market sales · 1,551 sh · avg $5.21 · $8,075 | ||||||
Loading xslF345X03/doc4.xml…